（来源：ETF炼金师）在过去的两周中，医药板块面临一定的回调压力，主要指数普遍呈现震荡下跌的态势。根据数据，恒生医疗保健指数在此期间录得-2.73%，而恒生港股通创新药精选指数则下降了1.57%，均未能赶上恒生指数的表现(+0.31%)。与此同时，医药50指数的表现更加疲弱，下降幅度达到3.73%，明显落后于申万医药生物指数(-1.12%)和沪深300指数(+0.39%)，这些波动的原因及未来的...
Source Link（来源：ETF炼金师）在过去的两周中，医药板块面临一定的回调压力，主要指数普遍呈现震荡下跌的态势。根据数据，恒生医疗保健指数在此期间录得-2.73%，而恒生港股通创新药精选指数则下降了1.57%，均未能赶上恒生指数的表现(+0.31%)。与此同时，医药50指数的表现更加疲弱，下降幅度达到3.73%，明显落后于申万医药生物指数(-1.12%)和沪深300指数(+0.39%)，这些波动的原因及未来的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.